TY - JOUR
T1 - Effect of chronic hyperglycemia on glucose metabolism in subjects with normal glucose tolerance
AU - Shannon, Chris
AU - Merovci, Aurora
AU - Xiong, Juan
AU - Tripathy, Devjit
AU - Lorenzo, Felipe
AU - McClain, Donald
AU - Abdul-Ghani, Muhammad
AU - Norton, Luke
AU - DeFronzo, Ralph A.
N1 - Funding Information:
Funding. This work was supported by the Foundation for the National Institutes of Health (DK24092-34 to R.A.D.). R.A.D.’s salary is supported, in part, by the South Texas Veterans Health Care System. Duality of Interest. No potential conflicts of interest relevant to this article were reported. Authors Contributions. C.S. contributed to the performance of the study and performed all of the molecular analyses and integrated the results with the in vivo metabolic results. A.M., J.X., D.T., F.L., and L.N. contributed to the performance of the study. D.M. contributed to the performance of the study and performed the hexosamine pathway analyses. M.A.-G. and R.A.D. contributed to the performance of the study and wrote the first draft of the manuscript, which was subsequently reviewed and revised by all the other authors. Prior Presentation. This study was presented as an abstract/poster at the 78th Scientific Sessions of the American Diabetes Association, Orlando, FL, 22–26 June 2018.
Publisher Copyright:
© 2018 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license..
PY - 2018/12/1
Y1 - 2018/12/1
N2 - Chronic hyperglycemia causes insulin resistance, but the inheritability of glucotoxicity and the underlying mechanisms are unclear. We examined the effect of 3 days of hyperglycemia on glucose disposal, enzyme activities, insulin signaling, and protein O-GlcNAcylation in skeletal muscle of individuals without (FH2) or with (FH+) family history of type 2 diabetes. Twenty-five subjects with normal glucose tolerance received a [3-3H]glucose euglycemic insulin clamp, indirect calorimetry, and vastus-lateralis biopsies before and after 3 days of saline (n = 5) or glucose (n = 10 FH2 and 10 FH+) infusion to raise plasma glucose by ∼45 mg/dL. At baseline, FH+ had lower insulin-stimulated glucose oxidation and total glucose disposal (TGD) but similar nonoxidative glucose disposal and basal endogenous glucose production (bEGP) compared with FH2. After 3 days of glucose infusion, bEGP and glucose oxidation were markedly increased, whereas nonoxidative glucose disposal and TGD were lower versus baseline, with no differences between FH2 and FH+ subjects. Hyperglycemia doubled skeletal muscle glycogen content and impaired activation of glycogen synthase (GS), pyruvate dehydrogenase, and Akt, but protein O-GlcNAcylation was unchanged. Insulin resistance develops to a similar extent in FH2 and FH+ subjects after chronic hyperglycemia, without increased protein O-GlcNAcylation. Decreased nonoxidative glucose disposal due to impaired GS activation appears to be the primary deficit in skeletal muscle glucotoxicity.
AB - Chronic hyperglycemia causes insulin resistance, but the inheritability of glucotoxicity and the underlying mechanisms are unclear. We examined the effect of 3 days of hyperglycemia on glucose disposal, enzyme activities, insulin signaling, and protein O-GlcNAcylation in skeletal muscle of individuals without (FH2) or with (FH+) family history of type 2 diabetes. Twenty-five subjects with normal glucose tolerance received a [3-3H]glucose euglycemic insulin clamp, indirect calorimetry, and vastus-lateralis biopsies before and after 3 days of saline (n = 5) or glucose (n = 10 FH2 and 10 FH+) infusion to raise plasma glucose by ∼45 mg/dL. At baseline, FH+ had lower insulin-stimulated glucose oxidation and total glucose disposal (TGD) but similar nonoxidative glucose disposal and basal endogenous glucose production (bEGP) compared with FH2. After 3 days of glucose infusion, bEGP and glucose oxidation were markedly increased, whereas nonoxidative glucose disposal and TGD were lower versus baseline, with no differences between FH2 and FH+ subjects. Hyperglycemia doubled skeletal muscle glycogen content and impaired activation of glycogen synthase (GS), pyruvate dehydrogenase, and Akt, but protein O-GlcNAcylation was unchanged. Insulin resistance develops to a similar extent in FH2 and FH+ subjects after chronic hyperglycemia, without increased protein O-GlcNAcylation. Decreased nonoxidative glucose disposal due to impaired GS activation appears to be the primary deficit in skeletal muscle glucotoxicity.
UR - http://www.scopus.com/inward/record.url?scp=85056802237&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056802237&partnerID=8YFLogxK
U2 - 10.2337/db18-0439
DO - 10.2337/db18-0439
M3 - Article
C2 - 30213826
AN - SCOPUS:85056802237
SN - 0012-1797
VL - 67
SP - 2507
EP - 2517
JO - Diabetes
JF - Diabetes
IS - 12
ER -